Needham Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Hold |
25,250
| – | – | 0.63% | 51 |
|
|
2025
Q4 | $14.6M | Sell |
25,250
-1,000
| -4% | -$566K | 0.92% | 37 |
|
|
2025
Q3 | $12.7M | Sell |
26,250
-250
| -0.9% | -$116K | 0.89% | 38 |
|
|
2025
Q2 | $10.7M | Hold |
26,500
| – | – | 0.86% | 39 |
|
|
2025
Q1 | $13.2M | Sell |
26,500
-2,750
| -9% | -$1.49M | 1.24% | 28 |
|
|
2024
Q4 | $15.2M | Hold |
29,250
| – | – | 1.17% | 29 |
|
|
2024
Q3 | $18.1M | Hold |
29,250
| – | – | 1.39% | 24 |
|
|
2024
Q2 | $16.2M | Hold |
29,250
| – | – | 1.33% | 21 |
|
|
2024
Q1 | $17M | Hold |
29,250
| – | – | 1.58% | 16 |
|
|
2023
Q4 | $15.5M | Hold |
29,250
| – | – | 1.96% | 11 |
|
|
2023
Q3 | $14.8M | Hold |
29,250
| – | – | 2.52% | 8 |
|
|
2023
Q2 | $15.3M | Sell |
29,250
-750
| -3% | -$405K | 2.51% | 11 |
|
|
2023
Q1 | $17.3M | Sell |
30,000
-4,000
| -12% | -$2.25M | 2.98% | 7 |
|
|
2022
Q4 | $18.7M | Hold |
34,000
| – | – | 3.39% | 5 |
|
|
2022
Q3 | $17.2M | Sell |
34,000
-500
| -1% | -$280K | 3.38% | 5 |
|
|
2022
Q2 | $18.7M | Sell |
34,500
-3,500
| -9% | -$1.93M | 3.5% | 3 |
|
|
2022
Q1 | $22.4M | Hold |
38,000
| – | – | 3.25% | 5 |
|
|
2021
Q4 | $25.4M | Hold |
38,000
| – | – | 3.18% | 7 |
|
|
2021
Q3 | $21.7M | Sell |
38,000
-3,500
| -8% | -$1.92M | 2.9% | 7 |
|
|
2021
Q2 | $20.9M | Hold |
41,500
| – | – | 3.06% | 6 |
|
|
2021
Q1 | $18.9M | Hold |
41,500
| – | – | 2.59% | 8 |
|
|
2020
Q4 | $19.3M | Sell |
41,500
-1,750
| -4% | -$821K | 3.24% | 5 |
|
|
2020
Q3 | $19.1M | Sell |
43,250
-3,750
| -8% | -$1.55M | 3.81% | 2 |
|
|
2020
Q2 | $17M | Sell |
47,000
-8,000
| -15% | -$2.68M | 3.64% | 5 |
|
|
2020
Q1 | $15.6M | Hold |
55,000
| – | – | 4.41% | 2 |
|
|
2019
Q4 | $17.9M | Hold |
55,000
| – | – | 4.87% | 3 |
|
|
2019
Q3 | $16M | Hold |
55,000
| – | – | 5.14% | 3 |
|
|
2019
Q2 | $16.2M | Sell |
55,000
-6,500
| -11% | -$1.79M | 5.33% | 3 |
|
|
2019
Q1 | $16.8M | Sell |
61,500
-6,350
| -9% | -$1.58M | 5.72% | 1 |
|
|
2018
Q4 | $15.2M | Sell |
67,850
-6,650
| -9% | -$1.56M | 5.7% | 1 |
|
|
2018
Q3 | $18.2M | Sell |
74,500
-10,000
| -12% | -$2.3M | 5.48% | 1 |
|
|
2018
Q2 | $17.5M | Sell |
84,500
-500
| -0.6% | -$106K | 4.91% | 1 |
|
|
2018
Q1 | $17.6M | Sell |
85,000
-2,500
| -3% | -$525K | 5.02% | 2 |
|
|
2017
Q4 | $16.6M | Sell |
87,500
-5,000
| -5% | -$958K | 4.42% | 3 |
|
|
2017
Q3 | $17.5M | Sell |
92,500
-2,000
| -2% | -$362K | 4.43% | 2 |
|
|
2017
Q2 | $16.5M | Sell |
94,500
-13,500
| -13% | -$2.27M | 4.39% | 3 |
|
|
2017
Q1 | $16.6M | Sell |
108,000
-32,500
| -23% | -$4.97M | 4.27% | 3 |
|
|
2016
Q4 | $19.8M | Sell |
140,500
-5,000
| -3% | -$737K | 5.07% | 2 |
|
|
2016
Q3 | $23.1M | Sell |
145,500
-5,000
| -3% | -$770K | 6.11% | 2 |
|
|
2016
Q2 | $22.2M | Sell |
150,500
-14,500
| -9% | -$2.14M | 6.14% | 2 |
|
|
2016
Q1 | $23.4M | Hold |
165,000
| – | – | 6.09% | 1 |
|
|
2015
Q4 | $23.4M | Hold |
165,000
| – | – | 5.82% | 2 |
|
|
2015
Q3 | $20.2M | Hold |
165,000
| – | – | 5.05% | 2 |
|
|
2015
Q2 | $21.4M | Hold |
165,000
| – | – | 4.64% | 3 |
|
|
2015
Q1 | $22.2M | Sell |
165,000
-2,500
| -1% | -$322K | 4.72% | 2 |
|
|
2014
Q4 | $21M | Buy |
167,500
+2,500
| +2% | +$304K | 4.42% | 5 |
|
|
2014
Q3 | $20.1M | Sell |
165,000
-35,000
| -18% | -$4.26M | 4.44% | 4 |
|
|
2014
Q2 | $23.6M | Sell |
200,000
-14,000
| -7% | -$1.65M | 4.92% | 2 |
|
|
2014
Q1 | $25.7M | Hold |
214,000
| – | – | 5.44% | 2 |
|
|
2013
Q4 | $23.8M | Hold |
214,000
| – | – | 4.93% | 2 |
|
|
2013
Q3 | $19.7M | Hold |
214,000
| – | – | 4.41% | 2 |
|
|
2013
Q2 | $18.1M | Buy |
+214,000
| New | +$17.8M | 4.23% | 3 |
|
Other funds holding TMO
VCM
Needham Investment Management's TMO Position: Q1 2026 in Review
Needham Investment Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 25,250 shares worth $12.4M. The position accounts for 0.63% of the portfolio, ranked #51.
Needham Investment Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.7M in Q1 2014. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Needham Investment Management held 25,250 shares of Thermo Fisher Scientific worth $12.4M as of Q1 2026.
- Needham Investment Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.63% of Needham Investment Management's portfolio in Q1 2026, its #51 holding.
- Needham Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Needham Investment Management's Thermo Fisher Scientific position peaked at $25.7M in Q1 2014.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Needham Investment Management's 13F filing for Q1 2026, filed 15 May 2026.